Brief: Valneva: FDA Lifts Temporary Pause Recommendation On Use Of IXCHIQ In Elderly
07/08/2025 06:17
Aug 7 (Reuters) - Valneva SE VLS.PA: REMOVAL OF FDA-RECOMMENDED PAUSE ON USE OF CHIKUNGUNYA VACCINE IXCHIQ IN ELDERLY FDA APPROVED UPDATES TO PRESCRIBING INFORMATION (PI) FOR IXCHIQ Source text: here Further company coverage: VLS.PA (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Valneva SE
See all newsBrief: UK MHRA Withdraws Marketing Authorisation for Ixchiq Chikungunya Vaccine After Safety Review
Valneva falls as UK regulator revokes Ixchiq vaccine authorisation
Brief: Valneva Provides Update On Ixchiq® In The United Kingdom
Valneva surges after EU regulator validates Lyme disease vaccine application
Brief: Pfizer And Valneva's Lyme Disease Vaccine Candidate Marketing Authorization Application Validated By European Medicines Agency